ASPM and glioblastoma: Finally, one of the most upregulated genes, ASPM, which has the highest fold change among DEGs, was further studied and identified in vitro and in vivo. The present study explored key DEGs and key pathways in GBM and identified ASPM as a promising therapeutic target of GBM.